Metabolic bone disorder clinical exome screening (limited panel of metabolic bone disorders and gastrointestinal disorders) was undertaken and revealed a class 4 likely pathogenic variant in the <i>LRP5</i> gene known to cause osteoporosis. This evidence concerns the gene LRP5 and metabolic bone disorder.